v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flow from operating activities:    
Net income $ 875.3 $ 977.0
Adjustments to reconcile net income to net cash flow from operating activities:    
Depreciation and amortization 377.5 306.4
Impairment of intangible assets 3.5 0.0
Excess and obsolescence charges related to inventory 14.3 44.4
Amortization of acquired inventory step-up 103.9 134.2
Share-based compensation 155.9 143.4
Contingent consideration 22.8 0.0
Deferred income taxes (59.1) (47.1)
(Gain) loss on strategic investments 33.2 61.6
Gain on sale of priority review voucher, net 0.0 (88.6)
Other 16.0 65.0
Changes in operating assets and liabilities, net of effects of business acquired:    
Inventory (27.9) (188.2)
Accrued expense and other current liabilities (318.7) (115.6)
Income tax assets and liabilities (534.7) (7.7)
Other changes in operating assets and liabilities, net (75.5) (103.0)
Net cash flow provided by (used in) operating activities 420.2 1,179.0
Cash flow from investing activities:    
Purchases of property, plant and equipment (63.7) (79.4)
Proceeds from sale of equity interest in Samsung Bioepis 0.0 406.8
Proceeds from sale of priority review voucher 0.0 103.0
Acquisitions of intangible assets (10.0) (84.1)
Proceeds from sales of strategic investments 0.0 57.5
Other (30.6) (3.3)
Net cash flow provided by (used in) investing activities (104.3) 400.5
Cash flow from financing activities:    
Payments related to issuance of stock for share-based compensation arrangements, net (18.2) (40.8)
Proceeds from borrowings 1,733.4 0.0
Repayments of borrowings (1,750.0) (650.0)
Other 0.1 6.0
Net cash flow provided by (used in) financing activities (34.7) (684.8)
Net increase (decrease) in cash and cash equivalents 281.2 894.7
Effect of exchange rate changes on cash and cash equivalents 102.6 (35.7)
Cash and cash equivalents, beginning of the period 2,375.0 1,049.9
Cash and cash equivalents, end of the period 2,758.8 1,908.9
Nonrelated Party    
Changes in operating assets and liabilities, net of effects of business acquired:    
Accounts receivable (170.5) 12.3
Related Party    
Changes in operating assets and liabilities, net of effects of business acquired:    
Accounts receivable $ 4.2 $ (15.1)